Interstitial cystitis, also called bladder pain syndrome (IC/BPS), can indeed cause leukocytes (white blood cells) to appear in urine, even when no bacterial infection is present. This finding, known clinically as sterile pyuria, is one of the more confusing aspects of the condition for patients and clinicians alike. The relationship between IC and urinary leukocytes is not straightforward, though, because it depends heavily on which subtype of the disease a person has and what kind of inflammation is driving their symptoms.
How IC Triggers White Blood Cells in Urine
IC/BPS is defined as a chronic bladder disorder involving suprapubic pain, pressure, or discomfort related to bladder filling, along with urinary frequency and urgency, lasting at least six weeks and occurring without a urinary tract infection.1PubMed Central. Urinary Biomarkers in Interstitial Cystitis/Bladder Pain Syndrome and Its Impact on Therapeutic Outcome The “without a urinary tract infection” part is critical. When your body fights a bacterial UTI, white blood cells flood into the urine as part of the immune response. But in IC, the bladder wall itself becomes chronically inflamed in ways that do not involve bacteria, and that inflammation can still shed white blood cells into the urine.
Mast cells play a central role in this process. These immune cells are stationed throughout the bladder wall and, in many IC patients, they become abnormally numerous and overactive. When activated, mast cells release chemical mediators that cause blood vessel dilation, direct damage to the bladder lining, and recruitment of other inflammatory cells into the tissue.2PubMed. The role of the mast cell in interstitial cystitis This cascade means that even without a single bacterium present, the bladder wall can be teeming with immune cells. Some of those cells make their way into the urine, where they show up as leukocytes on a dipstick or under a microscope. Research confirms that mast cell proliferation and activation are key contributors to IC pathology, though this pattern is more pronounced in some patients than others.3PubMed. The mast cell in interstitial cystitis: role in pathophysiology and pathogenesis
A study of women at the onset of IC symptoms found that microscopic white blood cell counts and positive dipstick leukocyte esterase results were significantly more common in those who had painful urination than in those who did not.4PubMed Central. Dysuria at onset of interstitial cystitis/painful bladder syndrome in women This makes intuitive sense: the more active the bladder inflammation, the more likely white blood cells are to appear in a urine sample. But it also means that IC patients without burning pain at a given moment may test clean on a urinalysis, which complicates diagnosis.
Why the Subtype of IC Matters Enormously
Not all IC is created equal, and the distinction between the two recognized subtypes changes whether you would expect leukocytes in the urine at all. IC with Hunner lesions, sometimes called classic or ulcerative IC, involves visible areas of inflammation and tissue breakdown on the bladder wall. IC without Hunner lesions, which is more common, looks dramatically different under the microscope.
Bladder biopsies from patients with Hunner lesions show a robust chronic inflammatory disease: the surface lining is stripped away, and the tissue beneath is packed with immune cell infiltration, fibrosis, and swelling. These inflammatory changes are not limited to the area around the lesion itself but span the entire bladder wall.5PubMed Central. Biomarkers in Interstitial Cystitis/Bladder Pain Syndrome with and without Hunner Lesion: A Review and Future Perspectives By contrast, IC without Hunner lesions shows only subtle changes, with the bladder lining largely preserved and very little inflammatory infiltration.6PubMed Central. Genomics and Histopathology in Interstitial Cystitis/Bladder Pain Syndrome
The practical implication is significant. If you have Hunner lesion IC, leukocytes in urine are a plausible and even expected finding because your bladder is genuinely inflamed at a tissue level, with immune cells actively infiltrating the wall. If you have non-Hunner IC, white blood cells in urine are less easily explained by the bladder condition itself and should prompt a closer look for other causes. Researchers now regard these two forms as fundamentally different conditions that happen to share a symptom profile. Hunner lesion disease features B-cell-dominant immune infiltration and urothelial destruction, while non-Hunner disease appears to involve mechanisms that do not center on classic bladder inflammation at all.6PubMed Central. Genomics and Histopathology in Interstitial Cystitis/Bladder Pain Syndrome
Sterile Pyuria and What It Means for Diagnosis
Sterile pyuria refers to finding white blood cells in the urine when a standard culture comes back negative for bacteria. It is a common finding in clinical practice, and IC/BPS is one of the recognized causes.7PubMed Central. Sterile pyuria: a practical management guide But the list of conditions that cause sterile pyuria is long and includes partially treated UTIs, sexually transmitted infections, kidney stones, urological tuberculosis, and foreign bodies in the urinary tract. IC is a diagnosis of exclusion, meaning clinicians have to rule out these other possibilities first.
This is where many patients hit a frustrating diagnostic loop. They go to a doctor with urinary symptoms, a dipstick shows leukocytes, and they get treated for a UTI. The antibiotics do nothing for their pain because there was never a bacterial infection. They return, the dipstick still shows leukocytes, and they get another round of antibiotics. IC evaluation often does not begin until this cycle has repeated several times. In men, the diagnostic workup includes urinalysis and possibly culture specifically to rule out infection before IC is even considered.8PubMed Central. Interstitial Cystitis/Bladder Pain Syndrome in Men
The core problem is that a positive leukocyte test is not a reliable indicator of infection. In a study evaluating pyuria as a surrogate marker for UTI, the positive predictive value was only about 0.40, meaning that fewer than half the samples with elevated white blood cells actually had a confirmed bacterial infection.9BJU International. Discrediting microscopic pyuria and leucocyte esterase as diagnostic surrogates for infection in patients with lower urinary tract symptoms For IC patients, this means positive leukocyte results can be entirely consistent with their condition rather than proof of a missed infection.
Dipstick Testing Has Real Limitations
The standard urine dipstick that checks for leukocyte esterase is a quick screening tool, but it is far from perfect. When researchers compared dipstick results against microscopic examination of urine sediment across thousands of samples, they found that the dipstick missed significant microscopic pyuria in a substantial proportion of cases. False-negative results for leukocytes occurred in about 16% of samples, meaning white blood cells were present but the dipstick said they were not.10PubMed Central. Discrepancy in results between dipstick urinalysis and urine sediment microscopy False positives for leukocytes were rarer, occurring in roughly 4% of samples.
There are also practical problems with sample handling. White blood cells in urine samples break down over time. Even with refrigeration and preservatives to slow the process, about 40% of cells were lost within four hours of collection.9BJU International. Discrediting microscopic pyuria and leucocyte esterase as diagnostic surrogates for infection in patients with lower urinary tract symptoms If your urine sample sat in a cup in the lab for a while before testing, the white blood cell count you get may underestimate what was actually there when you produced it. Centrifugation, another common laboratory step, had unpredictable effects on cell recovery. For IC patients trying to track their inflammation levels over time, these variables add noise to already ambiguous results.
Hidden Infections That Complicate the Picture
One reason IC diagnosis is so tricky is that standard urine cultures do not catch every organism. Certain bacteria, especially Mycoplasma and Ureaplasma species, do not grow on routine culture media. A systematic review recommended that in cases of symptomatic sterile pyuria with suspected IC or overactive bladder, clinicians should perform urethral swabs with PCR testing to check for these organisms.11PubMed Central. A Systematic Review of Mycoplasma and Ureaplasma in Urogynaecology
This is not purely academic. In a study of women with chronic urinary symptoms who had negative standard cultures, nearly half tested positive for Ureaplasma urealyticum. After targeted antibiotic treatment, their symptoms improved significantly, and follow-up cultures were negative.12PubMed. Association of chronic urinary symptoms in women and Ureaplasma urealyticum For someone who has been told they have IC based partly on sterile pyuria, discovering and treating one of these hidden infections could change the diagnosis entirely. If you have persistent leukocytes in urine with negative cultures and have not been tested for these organisms, it is worth raising the question with your doctor.
Beyond specific pathogens, newer research into the urinary microbiome suggests the bladder is not the sterile environment it was long assumed to be. In IC patients, microbial alterations do not follow a single recognizable pattern but converge on metabolic and immune disruption.13Nature Reviews Urology. The urinary microbiome, overactive bladder and bladder pain syndrome/interstitial cystitis — mechanisms, diagnostics and therapeutic opportunities This means the boundary between “infection” and “no infection” is blurrier than a standard culture result implies. The presence of leukocytes might reflect the immune system’s response to subtle microbial shifts that do not qualify as a traditional infection but still provoke inflammation.
Cytokines and the Search for Better Markers
The leukocyte esterase dipstick tells you whether white blood cells are present but nothing about why. Researchers have been working on more specific urinary biomarkers that could distinguish IC inflammation from other causes. When urine samples from IC patients were tested against healthy controls, several immune signaling molecules showed high diagnostic value. Proteins like RANTES and MIP-1β were sensitive at detecting IC, while others like MCP-1 and CXCL10 were better at specifically ruling it in. These markers remained statistically significant even after adjusting for age, sex, body mass index, and diabetes.14PubMed. Urine cytokines as biomarkers for diagnosing interstitial cystitis/bladder pain syndrome and mapping its clinical characteristics
Several of these cytokines also correlated with the severity of bladder wall changes seen during cystoscopy. MCP-1, CXCL10, eotaxin-1, and RANTES levels all rose in parallel with the degree of glomerulations (pinpoint bleeding spots on the bladder wall) and fell as bladder capacity increased.14PubMed. Urine cytokines as biomarkers for diagnosing interstitial cystitis/bladder pain syndrome and mapping its clinical characteristics These findings are still in the research stage and not yet part of routine clinical testing, but they point toward a future where a urine test could do more than just say “white blood cells present.” It could potentially tell you whether those white blood cells are there because of IC-specific inflammation, a bacterial infection, or something else entirely.
The Nerve-Inflammation Feedback Loop
One of the more frustrating aspects of IC is how inflammation becomes self-perpetuating. The immune signaling molecules released in the bladder wall do not just attract white blood cells; they also communicate with pain-sensing nerves. Through a nerve growth factor (NGF) signaling pathway, inflammatory cytokines sensitize pain receptors, which in turn release substance P, a neuropeptide that provokes more inflammation. This creates a positive feedback loop of neuroinflammation.15Discovery Medicine. Crosstalk Between the Immune System and Neural Pathways in Interstitial Cystitis/Bladder Pain Syndrome
This loop helps explain why IC symptoms can persist and flare even when there is no new trigger. Once the cycle is established, the nervous system and immune system keep each other revved up. For leukocytes in urine, this matters because the neuroinflammatory loop can sustain white blood cell recruitment to the bladder wall over long periods. A single normal urinalysis during a quiet phase does not mean inflammation has resolved. Conversely, a burst of leukocytes during a flare does not necessarily mean a new infection has set in. The immune system was already on high alert.
What Happens to Inflammation With Treatment
If IC-related inflammation drives leukocytes into the urine, reducing that inflammation should theoretically lower white blood cell counts. Animal research supports this idea. In a rat model of IC, intravesical hyaluronic acid treatment reduced the dense inflammatory cell infiltration in the bladder stroma to levels comparable to healthy controls. Myeloperoxidase activity, an enzyme marker of immune cell activity, also dropped to near-normal levels after treatment.16International Braz J Urol. Impact of intravesical hyaluronic acid treatment on bladder inflammation in interstitial cystitis rat model While animal studies do not translate directly to human outcomes, the finding supports the principle that targeting bladder wall inflammation can reduce the immune cell burden that leads to urinary leukocytes.
For patients tracking their own condition, this suggests that changes in urinary leukocyte levels over time might loosely reflect how well their bladder inflammation is being controlled, particularly for those with the Hunner lesion subtype. A urine dipstick is cheap and accessible, so even though it is an imperfect tool, some clinicians use it as one rough signal among many when monitoring treatment response. It is not reliable enough to serve as the sole guide, but a persistent rise in leukocytes after a period of stability could flag a flare or a superimposed infection worth investigating.
Vaginal Contamination and Other Sample Pitfalls
Before attributing leukocytes in urine to IC, it is worth knowing that contamination during sample collection is common, especially for women. Vaginal discharge frequently contains white blood cells, and without a clean-catch technique, these cells can end up in a urine cup and trigger a positive leukocyte esterase result. A midstream clean-catch sample reduces this problem but does not eliminate it entirely. If your leukocyte results are borderline or inconsistent between tests, contamination is a possibility worth discussing with your provider, particularly if you are not using a catheterized specimen.
Similarly, recent sexual activity, menstruation, and even vigorous exercise can temporarily elevate urinary white blood cells in people without any bladder disease. These transient causes are generally harmless but can produce false alarms that lead to unnecessary antibiotic prescriptions or diagnostic anxiety. For someone already navigating an IC diagnosis, understanding these confounders can save a lot of worry when a routine urinalysis comes back with unexpected leukocytes.
When Leukocytes in Urine Are Not From IC
IC patients are not immune to developing other conditions that cause urinary white blood cells. Kidney stones, for instance, can produce sterile pyuria through mechanical irritation of the urinary tract lining. Certain medications, particularly nonsteroidal anti-inflammatory drugs taken chronically, can cause interstitial nephritis, which also shows up as leukocytes in urine. Bladder cancer, though rare, is another cause that should not be overlooked, particularly in older patients with new or changing urinary symptoms.
The presence of leukocytes in someone with known IC should not be automatically dismissed as “just the IC” without some clinical thought. If the pattern changes, if new symptoms appear, or if red blood cells show up alongside white cells in higher numbers than usual, further evaluation is warranted. Urinalysis is a blunt instrument, and the same result can mean very different things depending on the clinical context.